All stock lists
Unlock the score
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
6.13-0.02 (-0.33%)
Insider Score
/ 100
ARTV Insider Score
Artiva Biotherapeutics, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
ARTV Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | -100.00 % |
| Cost of Revenue | 0.00 | 666.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -666.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 4.96 M | 5.12 M | 4.94 M | 5.26 M | 4.95 M | 5.12 M |
| R&D Expense | 21.93 M | 19.31 M | 16.99 M | 17.63 M | 17.86 M | 17.05 M |
| Operating Expenses | 26.89 M | 23.76 M | 21.93 M | 22.90 M | 22.81 M | 22.17 M |
| Operating Income | -26.89 M | -24.43 M | -21.93 M | -22.90 M | -22.81 M | -22.17 M |
| Pretax Income | -25.00 M | -23.52 M | -20.77 M | -21.53 M | -21.25 M | -20.31 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -25.00 M | -23.52 M | -20.77 M | -21.53 M | -21.25 M | -20.31 M |
| EPS (Basic) | -0.63 | -0.95 | -0.85 | -0.88 | -0.87 | -0.83 |
| EPS (Diluted) | -0.63 | -0.95 | -0.85 | -0.88 | -0.87 | -0.83 |
| Shares Outstanding | 39.41 M | 24.68 M | 24.44 M | 24.48 M | 24.38 M | 24.34 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.